Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 2Phase NA 1Phase 1/2 1

Status

Recruiting 3Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 94Thoracic 87Breast 41Head & Neck 26Gynecologic 24Other solid neoplasm 11Other hematologic neoplasm 11Lymphoid 11Genitourinary 9CNS 8Tumor-Agnostic 7Sarcoma 7Other 2Dermatologic 2Plasma cell 1Endocrine 1

Conditions

Neoplasm Metastasis 5Neoplasms 2

Interventions

pembrolizumab 55Specimen Handling 28Biopsy 28Magnetic Resonance Spectroscopy 27Paclitaxel 23Blood Specimen Collection 22Nivolumab 20atezolizumab 18Standard of Care 18Carboplatin 18Bevacizumab 18Surveys and Questionnaires 17Fluorouracil 14Oxaliplatin 13Cisplatin 13Leucovorin 12Cyclophosphamide 12Radiotherapy 11Radiosurgery 11Pemetrexed 11Capecitabine 11Irinotecan 10Gemcitabine 10Docetaxel 10Ipilimumab 9trastuzumab deruxtecan 8olaparib 8durvalumab 8Taxes 8Trastuzumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Drug Therapy × Tumor-Agnostic × 1 year × Clear all
NCT06803680 2026-05-22

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

BeOne Medicines

Phase 1 Recruiting
90 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT07498725 2026-03-27

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

LARKSPUR BIOSCIENCES, INC.

Phase 1/2 Not yet recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT06540066 2026-03-16

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

BeOne Medicines

Phase 1 Terminated
35 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05935098 2026-03-13

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

BeOne Medicines

Phase 1 Terminated
99 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05717166 2025-12-31

SABR-SYNC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Recruiting
180 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01558544 2025-12-10

Cryopreservation of Ovarian Tissue

Weill Medical College of Cornell University

Phase NA Recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

NCT03721341 2025-09-18

SABR-COMET 10

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Active not recruiting
204 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡